In vitro Anti-sickling Activity of Red Grape Juice (Vitis vinifera L. var. Crimson Seedless) on Human HbSS Erythrocytes
Abstract
Introduction: Sickle cell disease is characterized by sickle hemoglobin (HbS) polymerization under deoxygenation conditions, causing erythrocyte sickling, hemolysis, and vaso-occlusive complications. Red grape polyphenols exhibit antioxidant properties that may contribute to erythrocyte protection. This study aimed to evaluate the in vitro anti-sickling activity of red grape juice (Vitis vinifera L. var. Crimson Seedless) on HbSS erythrocytes. Methods: An experimental in vitro study was conducted using blood samples from SS phenotype donors. Sickling was induced with 2% sodium metabisulfite according to the Emmel test. Erythrocytes were treated with three grape juice dilutions (1/10, 1/100, and 1/1000). Sickled erythrocytes were quantified by light microscopy, and sickling inhibition was calculated relative to the control. Results were obtained from six independent biological experiments. Results: Red grape juice reduced erythrocyte sickling in a concentration-dependent manner. The highest inhibitory activity was observed at the 1/10 dilution, with 58.52% inhibition, while the 1/100 and 1/1000 dilutions showed lower inhibition rates of 16.03% and 8.24%, respectively. Microscopic analysis showed better preservation of erythrocyte morphology at the 1/10 dilution. Conclusion: Red grape juice (Vitis vinifera L. var. Crimson Seedless) exhibits in vitro anti-sickling activity on HbSS erythrocytes. These findings suggest a potential interest in grape-derived bioactive compounds as complementary candidates for sickle cell disease research. Further studies are needed to identify active compounds, assess safety, and confirm efficacy in preclinical and clinical models.
Keywords: Sickle cell disease; SS erythrocytes; anti-sickling activity; Vitis vinifera; Crimson Seedless; polyphenols; Emmel test.
Keywords:
Sickle cell disease, anti-sickling activity, Vitis vinifera, polyphenolsDOI
https://doi.org/10.22270/jddt.v16i8.7944References
1. Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. The Lancet. 2010;376(9757): 2018‑2031. PMCid:PMC11664321 PMid:21131035 https://doi.org/10.1016/S0140-6736(10)61029-X
2. Hoban MD, Orkin SH, Bauer DE. Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell disease. Blood J Am Soc Hematol. 2016;127(7):839‑848. https://doi.org/10.1182/blood-2015-09-618587 PMid:26758916 PMCid:PMC4760089
3. Platt OS. Sickle cell paths converge on hydroxyurea. Nat Med. 1995;1(4):307‑308. https://doi.org/10.1038/nm0495-307 PMid:7585059
4. Bonarska-Kujawa D, Pruchnik H, Kleszczyńska H. Interaction of selected anthocyanins with erythrocytes and liposome membranes. Cell Mol Biol Lett. 2012 Jun;17(2):289-308. https://doi.org/10.2478/s11658-012-0010-y PMid:22396139 PMCid:PMC6275648
5. Xia E-Q, Deng G-F, Guo Y-J, Li H-B. Biological Activities of Polyphenols from Grapes. Int J Mol Sci. 2010;11(2):622‑646. https://doi.org/10.3390/ijms11020622 PMid:20386657 PMCid:PMC2852857
6. Eaton WA. Hemoglobin S polymerization and sickle cell disease: A retrospective on the occasion of the 70th anniversary of Pauling’s Science paper. Am J Hematol. 2020; 95(2): 205‑211. https://doi.org/10.1002/ajh.25687 PMid:31763707 PMCid:PMC7003899
7. Scalbert A, Johnson IT, Saltmarsh M. Polyphenols: antioxidants and beyond. Am J Clin Nutr. 2005;81(1):215S-217S. https://doi.org/10.1093/ajcn/81.1.215S PMid:15640483
8. Mokra D, Joskova M, Mokry J. Therapeutic effects of green tea polyphenol (-)-Epigallocatechin-3-Gallate (EGCG) in relation to molecular pathways controlling inflammation, oxidative stress, and apoptosis. Int J Mol Sci. 2022;24(1):340. PMCid:PMC9820274 https://doi.org/10.3390/ijms24010340 PMid:36613784
Published
Abstract Display: 48 
PDF Downloads: 54 PDF Downloads: 12 How to Cite
Issue
Section
Copyright (c) 2026 Ndèye Absatou Diaw, Youssou Thiendella Fall , Ibrahima Diouf, Awa Ba Diop , Mbaye Sene, Mamadou Sarr , Modou Oumy Kane
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.